Live Breaking News & Updates on Powderject Pharmaceuticals

Stay updated with breaking news from Powderject pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Wireless mode taps stealth potential

Wireless mode taps stealth potential
defenceweb.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenceweb.co.za Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Paul Drayson , Gordon Brown , United Kingdom Parliament , Department Of Defence , Powderject Pharmaceuticals , Defence Advanced Research Projects Agency , Sandia National Laboratories , World Wide Wrap , American Le Mans ,

BioNTech (NASDAQ:BNTX) and Illumina (NASDAQ:ILMN): 10x Returns to Investors

The equity analysts that correctly identified BioNTech (NASDAQ:BNTX) and Illumina (ILMN) for investors deserve a closer look. ....

New York , United States , France General , Cornell University , New York University , Hambrecht Quist , Suntrust Robinson Humphrey , Soumit Roy , Mizuho Soumit Roy , Credit Suisse Group , University Of Buffalo , Pfizer Inc , York University , Oxford University , Albert Einstein College Of Medicine , Credit Suisse , Neon Therapeutics Inc , Powderject Pharmaceuticals In Oxford , Clinical Immunology Department , Icahn School Of Medicine At Mount Sinai , Healthcare Analyst Of Jones Trading Institutional Services , University Of Pennsylvania , Jones Trading Institutional Services , Vamil Divan , Managing Director , Mizuho Securities ,

Arix Bioscience PLC: Board Changes

Arix Bioscience PLC: Board Changes
DJ Board Changes
Arix Bioscience PLC (ARIX)
Board Changes
25-Feb-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
Arix Bioscience plc
Board Changes
LONDON, 25 February 2021: Arix Bioscience plc ( Arix or the Company ) (LSE: ARIX), a global venture capital company
focused on investing in and building breakthrough biotech companies, today announces that James Noble and Axel Wieandt
will each be joining the Board as Non-Executive Directors, effective 1 April 2021.
The company also announces that Mark Breuer, Non-Executive Director, will step down from the Board on 1 April 2021, ....

United Kingdom , City Of , Supriya Mathur , Oxford Glycosciences , Mark Breuer , Charlotte Parry , Shabnam Bashir , Axel Wieandt , James Noble , Arix Bioscience , Naseem Amin , Kleinwort Benson , Giles Kerr , Morgan Stanley , German Deposit Insurance Fund , Valovis Bank , Stockholm Stock Exchange , Gw Pharmaceuticals , Audit Committee , News Service , Deutsche Bank As Head Of Corporate Development , Goethe University In Frankfurt , Lotto Beisheim School Of Management , University Of Oxford , School Of Management , Powderject Pharmaceuticals ,